Background Investigation Methods, Corporate Intelligence & Due Diligence, e-Discovery Techniques, Investigation & Intelligence Feeds, Judgment Enforcement, Legal Enforcement Cases, Legal Ethics & Intelligence, Legal Technology & Intelligence, Witness Credibility Analysis

Hikma Launches Ustekinumab Biosimilar STARJEMZA

Posted by author-avatar
0
Test Logo Transparent

On November 6, 2025, Hikma Pharmaceuticals PLC, and its subsidiary Hikma Pharmaceuticals USA Inc., announced the launch of STARJEMZA (ustekinumab-hmny).  STARJEMZA references Janssen’s STELARA, and is indicated for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis….
By: Goodwin

Newer
Prosecutorial Error: ‘AI Hallucinations’ Are Popping Up In Criminal Cases
Back to list
Older Microsoft Backs Massive AI Push in UAE, Raising Security Concerns

Leave a Reply

Your email address will not be published. Required fields are marked *